Children with obesity have increased rates of dermatologic conditions
Children with obesity have increased rates of dermatologic conditions, according to a study published online Feb. 10 in Pediatric Dermatology.
Feb 26, 2025
0
0
Skin and Connective Tissue Diseases: News and Research on Hidradenitis Suppurativa
MeSH tree: C17.800.946.315.320
FDA approves Bimzelx for hidradenitis suppurativa
The U.S. Food and Drug Administration has approved UCB's Bimzelx (bimekizumab-bkzx) for the treatment of adults with moderate-to-severe hidradenitis suppurativa.
Nov 26, 2024
0
1
Protein disruption reveals potential treatment option for people with debilitating skin condition
Hidradenitis suppurativa, commonly referred to as HS, is a debilitating skin condition that causes chronic inflammation on the surface of the skin. This condition is characterized by painful bumps or boils that form under ...
Nov 20, 2024
0
31
Longitudinal study links skin disorder to increased maternal and child health risks
University of Montreal and McGill University researchers in Canada have identified a significant association between hidradenitis suppurativa (HS) and higher risks of adverse pregnancy outcomes, as well as long-term health ...
Bimekizumab safe, efficacious over two years for hidradenitis suppurativa
For patients with hidradenitis suppurativa (HS), bimekizumab is safe and efficacious over two years, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. ...
Oct 7, 2024
0
1
Semaglutide improves outcomes for obese patients with common skin condition, new study shows
A pioneering study, presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic ...
Sep 25, 2024
0
1
Chronic skin disorder risk reduces over smoke-free years
The University of Cincinnati's Robert Van Haren was featured in a MedCentral article discussing recent research that found smoking cessation significantly reduced the risk of developing hidradenitis suppurativa, a non-contagious ...
Sep 5, 2024
0
0
Bimekizumab yields meaningful response in hidradenitis suppurativa
Bimekizumab is well tolerated and produces clinically meaningful responses in patients with hidradenitis suppurativa, according to a study published online May 22 in The Lancet.
May 30, 2024
0
0
Clinical markers improve with IV ertapenem for hidradenitis suppurativa
Treatment of hidradenitis suppurativa (HS) with intravenous ertapenem is associated with improvement in clinical and inflammatory markers, according to a study published online Feb. 19 in JAMA Dermatology.
Feb 21, 2024
0
0
Factors ID'd that affect medical decision-making in hidradenitis suppurativa
Factors that affect medical decision-making among patients with hidradenitis suppurativa (HS) include suffering threshold, perceptions of treatment risk, treatment fatigue, understanding of the disease, and sources of information, ...
Jan 17, 2024
0
0
